Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799705 · ClinicalTrials.gov registry record
Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 132
- Enrollment target
NCT03799705: Completed study, sponsored by Mayo Clinic.
NCT03799705 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03799705 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.
Primary Outcome
Identification of genetic variants which may be associated with VACTERL association or other congenital malformations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2022-12-01 |
What the finished NCT03799705 record still lists
NCT03799705 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03799705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03799705 about?
NCT03799705 is a clinical study titled "Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway". Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.
What is the current status of trial NCT03799705?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2019-12-01. Estimated completion is 2022-12-01.
Who is sponsoring clinical trial NCT03799705?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI